Beneficial effects of hyperbaric oxygen on human degenerated intervertebral disk cells via suppression of IL-1β and p38 MAPK signal

Journal of Orthopaedic Research

Volumn 29, Issue 1, 2011, Pages 14-19

  Niu, Chi Chien ^a,b   Yuan, Li Jen ^a,b   Chen, Lih Huei ^a,b   Lin, Song Shu ^a,c   Tsai, Tsung Ting ^a,b   Liao, Jen Chung ^a,b   Lai, Po Liang ^a,b   Chen, Wen Jer ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

disk degeneration; hyperbaric oxygen; MMP 3; p38 MAPK; TIMP 1

Indexed keywords

AGGRECAN; COLLAGEN TYPE 2; INTERLEUKIN 1; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PROSTAGLANDIN E2; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CATABOLISM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERBARIC OXYGEN; HYPEROXIA; INFLAMMATION; INTERVERTEBRAL DISK DEGENERATION; NUCLEUS PULPOSUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION;

AGGRECANS; CELLS, CULTURED; COLLAGEN TYPE II; DINOPROSTONE; HUMANS; HYPERBARIC OXYGENATION; INTERLEUKIN-1BETA; INTERVERTEBRAL DISK DEGENERATION; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 3; NITRIC OXIDE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 78649625147     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21195     Document Type: Article

References (33)

1. Kang JD, Georgescu HI, Lori ML, et al. 1997. Toward a biochemical understanding of human intervertebral disc degeneration and herniation contributions of nitric oxide, interleukins, prostaglandin E2, and matrix Metalloproteinases. Spine 22: 1065-1073.
2. Podichetty VK,. 2007. The aging spine: The role of inflammatory mediators in intervertebral disc degeneration. Cell Mol Biol 53 (5): 4-18.
3. Wang YJ, Shi Q, Lu WW, et al. 2006. Cervical intervertebral disc degeneration induced by unbalanced dynamic and static forces: A novel in vivo rat model. Spine 31: 1532-1538.
4. LeMaitre CL, Freemont AJ, Hoyland JA,. 2005. The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther 7: R732-R745.
5. LeMaitre CL, Freemont AJ, Hoyland JA,. 2004. Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J Pathol 204: 47-54.
6. Kanemoto M, Hukuda S, Komiya Y, et al. 1996. Immunohistochemical study of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in human intervertebral discs. Spine 21: 1-8.
7. Anderson DG, Izzo MW, Hall DJ, et al. 2002. Comparative gene expression profiling of normal and degenerative discs. Spine 27: 1291-1296.
8. Sobajima S, Shimer AL, Chadderdon RC, et al. 2005. Quantitative analysis of gene expression in a rabbit model of intervertebral disc degeneration by real-time polymerase chain reaction. Spine J 5: 14-23.
9. van der Kraan PM, van den Berg WB,. 2000. Anabolic and destructive mediators in osteoarthritis. Curr Opin Clin Nutr Metab Care 3: 205-211.
10. Studer RK, Aboka AM, Gilbertson LG, et al. 2007. p38 MAPK inhibition in nucleus pulposus cells: A potential target for treating intervertebral disc degeneration. Spine 32: 2827-2833.
11. Studer RK, Gilbertson LG, Georgescu H, et al. 2008. p38 MAPK inhibition modulates rabbit nucleus pulposus cell response to IL-1. J Orthop Res 26: 991-998.
12. Studer RK, Chu CR,. 2005. p38 MAPK and COX2 inhibition modulate human chondrocyte response to TGF-beta. J Orthop Res 23: 454-461.
13. Korhonen K, Kuttila K, Niinikoski J,. 1999. Subcutaneous tissue oxygen and carbon dioxide tensions during hyperbaric oxygenation: An experimental study in rats. Eur J Surg 165: 885-890.
14. Weisz G, Lavy A, Adir Y, et al. 1997. Modification of in vivo and in vitro TNF-a, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease. J Clin Immunol 17: 154-159.
15. Veltkamp R, Bieber K, Wagner S, et al. 2006. Hyperbaric oxygen reduces basal lamina degradation after transient focal cerebral ischemia in rats. Brain Res 1076: 231-237.
16. Ostrowski RP, Jadhav V, Chen W, et al. 2010. Reduced matrix metalloproteinase-9 activity and cell death after global ischemia in the brain preconditioned with hyperbaric oxygen. Acta Neurochir 106: 47-49.
17. Takeyama N, Sakai H, Ohtake HA, et al. 2007. Effects of hyperbaric oxygen on gene expressions of procollagen, matrix metalloproteinase and tissue inhibitor of metalloproteinase in injured medial collateral ligament and anterior cruciate ligament. Knee Surg Sports Traumatol Arthrosc 15: 443-452.
18. Sander AL, Henrich D, Muth CM, et al. 2009. In vivo effect of hyperbaric oxygen on wound angiogenesis and epithelialization. Wound Rep Reg 17: 179-184.
19. Yamashita S, Hirata T, Mizukami Y, et al. 2009. Repeated preconditioning with hyperbaric oxygen induces neuroprotection against forebrain ischemia via suppression of p38 mitogen activated protein kinase. Brain Res 1301: 171-179.
20. Yuan LJ, Ueng SWN, Lin SS, et al. 2004. Attenuation of apoptosis and enhancement of proteoglycan synthesis in rabbit cartilage defects by Hyperbaric oxygen treatment are related to the suppression of nitric oxide production. J Ortho Res 22: 1126-1134.
21. Risbud MV, Guttapalli A, Albert TJ, et al. 2005. Hypoxia activates MAPK activity in rat nucleus pulposus cells. Spine 30: 2503-2509.
22. Rannou F, Corvol MT, Hudry C, et al. Sensitivity of anulus fibrosus cells to interleukin 1 beta. Comparison with articular chondrocytes. Spine 2000. 25: 17-23.
23. Maeda S, Kokubun S,. 2000. Changes with age in proteoglycan synthesis in cells cultured in vitro from the inner and outer rabbit annulus fibrosus. Responses to interleukin-1 and interleukin-1 receptor antagonist protein. Spine 25: 166-169.
24. Ishii Y, Ushida T, Tateishi T, et al. 2002. Effects of different exposures of hyperbaric oxygen on ligament healing in rats. J Orthop Res 20: 353-356.
25. Chan YS, Chen ACY, Yuan LJ, et al. 2007. Effects of hyperbaric oxygen and platelet derived growth factor on medial collateral ligament fibroblasts. Undersea Hyperb Med 34: 1-10.
26. Lee JC, Laydon JT, McDonnell PC, et al. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739-746.
27. Al-Waili NS, Butler GJ,. 2006. Effects of hyperbaric oxygen on inflammatory response to wound and trauma: Possible mechanism of action. Sci World J 6: 425-441.
28. Niu KC, Huang WT, Lin MT, et al. 2009. Hyperbaric oxygen causes both anti-inflammation and anti-pyresis in rabbits. Eur J Pharmacol 606: 240-245.
29. Miyamoto H, Saura R, Coita M, et al. 2002. The role of cyclooxygenase-2 in lumbar disc herniation. Spine 27: 2477-2483.
30. Kang JD, Stefanovic-Racic M, McIntyre LA, et al. 1997. Toward a biochemical understanding of human intervertebral disc degeneration and herniation: Contributions of nitric oxide, interleukins, prostaglandin E2, and matrix metalloproteinases. Spine 22: 1065-1073.
31. Nemoto H, Yamagishi M, Kikuchi T, et al. 1994. Effect of IL-1 and IL-6 on MMP-3 and TIMP-1 production in human degenerated disc tissue. Rinsho Seikei Geka 29: 369-376.
32. Yamaguchi I, Tojyo I, Yoshida H, et al. 2005. Role of hypoxia and interleukin-1β in gene expressions of matrix metalloproteinases in temporomandibular joint disc cells. Arch Oral Biol 50: 81-87.
33. Thom SR,. 2009. Oxidative stress is fundamental to hyperbaric oxygen therapy. J Appl Physiol 106: 988-995.